Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclodextrin gel for recurrent genital herpes simplex virus infections
2005-001705-26Phase 2Completed
- Sponsor
- Galderma
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of beta-cyclodextrin in genital herpes and herpes simplex (HSV) (2 arms), sponsored by Galderma. Primary endpoint: Duration to crusting of vesicles. Started Oct 2005; status: completed.
02
Drugs
beta-cyclodextrin
03
Conditions
genital herpesherpes simplex (HSV)
Beyond the preview
Go deeper on 2005-001705-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001705-26.